Recombinant Anti-albumin x Anti-TNF Bispecific Antibody (VHH-IgG) (BSSG-357)

Recombinant Anti-albumin x Anti-TNF Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-TNF antibody variable domain are respectively connected to the N terminus of the anti-albumin IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can act as PK-modulated ligand antagonist. It is designed for the research of Lupus and rheumatoid arthritis therapy.

Datasheet INQUIRY

Specifications

Targets

albumin & TNF

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Systemic lupus erythematosus (SLE); Rheumatoid arthritis (RA)

Targets

Target 1

albumin

Gene ID

213

UniProt ID

P02768

Alternative Names

ALB; albumin; HAS; PRO0883; PRO0903; PRO1341

Target 2

TNF

Gene ID

7124

UniProt ID

P01375

Alternative Names

TNF; tumor necrosis factor; DIF; TNFA; TNFSF2; TNF-alpha; TNFα; cachectin; APC1 protein; TNF, monocyte-derived; TNF-α; TNF, macrophage-derived; tumor necrosis factor-alpha; tumor necrosis factor ligand superfamily member 2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-albumin x Anti-TNF Bispecific Antibody (VHH-IgG) (BSSG-357). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-albumin x Anti-TNF Bispecific Antibody (VHH-IgG) (CAT#: BSSG-357)

Specifications

Targets

Customer Reviews and Q&As